Chenyu Mao

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Network Analysis

Ejection Fraction

Metastatic Breast Cancer

Top Venues

Immunity, inflammation and disease

Current oncology (Toronto, Ont.)

Functional & integrative genomics

Molecular and cellular biochemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Chenyu Mao, Ye He, Nong Xu, Haijiao Yan, Ningling Zhang, Gang Cheng, Hua Jiang, Minbin Chen, Yong Chen, Xiaoguang Wang, Yulan Gu, Peng Shen, Guifang Zhang, Jun Yan, Zhe Yang, Lifang Ding, Zhengxiang Han, Zhanggui Wang, Junqi Zhang, Weie Zheng, Jufeng Wang, Shu-Kui Qin
A multicenter, prospective, non-interventional real-world study to assess the effectiveness of mecapegfilgrastim in preventing neutropenia in patients with gastrointestinal cancer. Immunity, inflammation and disease 12 (8) (2024)
Chenyu Mao, Ye He, Nong Xu, Haijiao Yan, Ningling Zhang, Gang Cheng, Hua Jiang, Minbin Chen, Yong Chen, Xiaoguang Wang, Yulan Gu, Peng Shen, Guifang Zhang, Jun Yan, Zhe Yang, Lifang Ding, Zhengxiang Han, Zhanggui Wang, Junqi Zhang, Weie Zheng, Jufeng Wang, Shu-Kui Qin
A multicenter, prospective, non-interventional real-world study to assess the effectiveness of mecapegfilgrastim in preventing neutropenia in patients with gastrointestinal cancer. Immunity, inflammation and disease 12 (8) (2024)
Xiaolu Ma, Yongfeng Ding, Jiong Qian, Mingyu Wan, Ning Li, Chenyu Mao, Cheng Xiao, Haiping Jiang, Yulong Zheng, Luntao Wu, Xiaoyu Chen, Haiping Jiang
Nomogram Based on Monocyte-to-Lymphocyte Ratio to Predict Survival of Unresectable Esophageal Squamous Cell Carcinoma Who Receive First-Line PD-1/PD-L1 Inhibitors Combined with Chemotherapy. Current oncology (Toronto, Ont.) 29 (11) (2022)
Chenyu Mao, Yuan Gao, Mingyu Wan, Nong Xu
Identification of glycolysis-associated long non-coding RNA regulatory subtypes and construction of prognostic signatures by transcriptomics for bladder cancer. Functional & integrative genomics 22 (4) (2022)
Chenyu Mao, Yongfeng Ding, Nong Xu
Semen as a rich source of diagnostic biomarkers for prostate cancer: latest evidence and implications. Molecular and cellular biochemistry (2021)